Tool overview
Nabla Bio is listed under AI for Science AI tools.
What is Nabla Bio?
Nabla Bio combines generative molecular modeling with high-throughput wet-lab measurements to design antibodies, multispecifics, and other biologics with target-aware function and developability from the start.
Best for
Pharmaceutical teams designing novel antibodies and complex biologics
Who is it for?
Decision note
Pricing research outcome: Contact sales. Use only the confirmed compact values and official pricing source; do not infer unconfirmed free access, trials, API terms, languages, or affiliate status.
Key features
JAM and JAM-2 generative biologics design
Target- and epitope-aware antibody generation
High-throughput human-relevant wet-lab measurements
Developability and affinity optimization
Multispecific and custom biologic architectures
Platform partnerships and molecule licensing
Use cases
Designing de novo therapeutic antibodies
Exploring hard-to-drug targets and epitopes
Optimizing affinity and developability
Building multispecific biologic candidates
Licensing computationally designed molecules
Pros
- Integrates model design with wet-lab evidence
- Targets drug-like properties from the start
- Supports multiple biologic formats
- Offers direct pharmaceutical partnering routes
Limitations
Nabla Bio accelerates biologics design but does not replace preclinical studies, toxicology, manufacturing development, clinical validation, regulatory review, or partner responsibility for development decisions.
Pricing details
Billing options
Custom research partnership or molecule license
Pricing note
Nabla Bio does not publish standard prices. Commercial access is arranged through a custom pharmaceutical platform partnership or molecule-licensing agreement based on program scope and development responsibilities.
Supported languages
- English
Integrations
JAM
JAM-2
Partner discovery pipelines
Please log in to join the discussion.